Equities

Vivione Biosciences Inc

VBI.H:NEX

Vivione Biosciences Inc

Actions
  • Price (CAD)0.015
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Mar 16 2017.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Vivione Biosciences Inc. is a holding company which is currently reviewing potential acquisitions. The Company’s subsidiary is Vivione Biosciences, LLC.

  • Revenue in CAD (TTM)0.00
  • Net income in CAD-174.77k
  • Incorporated2011
  • Employees--
  • Location
    Vivione Biosciences IncEight Greenway Plaza, Suite 1320HOUSTON 77046United StatesUSA
  • Phone+1 (713) 475-0321
  • Fax+1 (509) 561-7287
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Searchlight Innovations Inc0.00-58.62k612.00k----5.16-----0.0115-0.01150.000.02330.00-------35.02---39.61--------------0.00------20.74------
MDK Acquisition Inc0.00-107.49k621.00k----3.47-----0.0173-0.01730.000.0289----------------------------0.00-------239.67------
Madeira Minerals Ltd0.00-63.76k621.88k-----------0.0034-0.00340.00-0.00810.00-------265.17-70.13----------------34.75------20.97------
Bow Lake Capital Corp0.00-19.02k624.00k----1.41-----0.0042-0.00420.000.05670.00-------4.15---4.21--------------0.00------78.81------
Kua Investments Inc0.00-92.75k625.00k----5.00-----0.0148-0.01480.000.020.00-------50.25---57.40--------------0.00------27.71------
Planet X Capital Corp0.00-17.40k635.50k----4.29-----0.0042-0.00420.000.03610.00-------11.29---11.31--------------0.00------64.40------
Planet X II Capital Corp0.00-17.28k635.50k----4.15-----0.0042-0.00420.000.03730.00-------10.85---10.86--------------0.00------66.33------
Compass Venture Inc0.00-122.07k636.20k----2.40-----0.0116-0.01160.000.0250.00-------32.36---37.41--------------0.00-------77.78------
Vivione Biosciences Inc0.00-174.77k644.07k-----------0.0026-0.00260.00-0.00510.00-------85.04-107.14---953.63-------936.16-------------54.97------
Pacific GeoInfo Corp-100.00bn-100.00bn649.99k--------------------------------------------------------------
Reem Capital Corp0.00-65.97k658.38k-----------0.0084-0.00840.000.03570.00-------16.41---20.94--------------0.00------34.78------
Jinhua Capital Corp0.00-365.16k672.39k----1.21-----0.03-0.030.000.00830.00-------106.07-402.24-5,239.02-------------170.440.1248-------83.66------
Totec Resources Ltd0.00-86.23k673.86k----2.87-----0.0215-0.02150.000.03840.00-------52.15---54.98--------------0.00-------372.27------
US Financial 15 Split Corp.403.08k0.00675.59k--------1.680.000.000.2121--0.0324--6.97---10.031.48----78.4774.68-309.8955.97--0.109-----1.31-6.25--------
Logica Ventures Corp0.00-88.02k676.17k-----------0.0306-0.03060.00-0.01780.00-------125.74---------------------------200.06------
Data as of Mar 16 2017. Currency figures normalised to Vivione Biosciences Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.